Articles From: Oncolytics Biotech® Inc. Announces Second Quarter 2014 Results to One Horizon Group Closes $1 Million Private Placement


2014/8/7
Oncolytics Biotech® Inc. Announces Second Quarter 2014 Results Canada NewsWire CALGARY , Aug.
Sign-up for Oncolytics Biotech® Inc. Announces Second Quarter 2014 Results investment picks
2014/8/7
CALGARY , Aug.
Sign-up for Oncolytics Biotech® Inc. Announces Second Quarter 2014 Results investment picks
REDWOOD CITY, Calif., Aug.
Sign-up for OncoMed Pharmaceuticals Announces Removal of Partial Clinical Hold by the FDA for Vantictumab investment picks
REDWOOD CITY, Calif., Aug.
Sign-up for OncoMed Pharmaceuticals Announces Second Quarter 2014 Financial Results investment picks
REDWOOD CITY, Calif., July 16, 2014 (GLOBE NEWSWIRE) -- OncoMed Pharmaceuticals, Inc. (Nasdaq:OMED) , a clinical-stage company developing novel therapeutics that target cancer stem cells (CSCs), or tumor-initiating cells, today announced that patient dosing has begun in the randomized, placebo-controlled Phase 2 portion of the company's " ALPINE " ( A ntibody therapy in first- L ine P ancreatic cancer I nvestigating anti- N otch E fficacy and safety) clinical trial of its anti-Notch 2/3 cancer stem cell antibody, tarextumab (OMP-59R5), being studied for the treatment of pancreatic cancer.
Sign-up for OncoMed Pharmaceuticals Initiates Randomized Phase 2 "ALPINE" Clinical Trial of Tarextumab (Anti-Notch 2/3, OMP-59R5) for Pancreatic Cancer investment picks
REDWOOD CITY, Calif., Oct.
Sign-up for OncoMed Pharmaceuticals to Present at the 13th Annual BIO Investor Forum investment picks
REDWOOD CITY, Calif., Sept.
Sign-up for OncoMed Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Conference investment picks
MADRID and REDWOOD CITY, Calif, Sept.
Sign-up for OncoMed's Demcizumab Phase 1b Clinical Trials Show Encouraging Safety and Anti-Tumor Activity at ESMO investment picks
OncoSec Medical Inc. (OTCQB: ONCS ), a company developing DNA-based intratumoral cancer immunotherapies, will attend or present at three events in October.
Sign-up for OncoSec Medical Announces October Events Agenda investment picks
OncoSec Medical Inc. (OTCQB: ONCS ), a company developing its ImmunoPulse DNA-based intratumoral cancer immunotherapy, has appointed Dr.
Sign-up for OncoSec Medical Appoints Dr. Holbrook Kohrt to Scientific Advisory Board investment picks
2014/8/11
Oncothyreon to Leverage Alpine's Protocell Technology to Enable Targeted Delivery of Molecular Therapeutics for Serious Diseases Company to Hold Conference Call at 4:30 p.m. EDT Today SEATTLE, WA , Aug.
Sign-up for Oncothyreon Announces Acquisition of Alpine Biosciences investment picks
SEATTLE, WA , Sept.
Sign-up for Oncothyreon Announces Proposed Public Offerings investment picks
Company to Hold Conference Call at 4:30 p.m. EDT Today SEATTLE, WA , Aug.
Sign-up for Oncothyreon Reports Second Quarter 2014 Financial Results investment picks
SEATTLE , Sept.
Sign-up for Oncothyreon to Present at Rodman & Renshaw Global Investment Conference investment picks
TULSA, Okla.
Sign-up for ONE Gas Declares Third-quarter Dividend investment picks
TULSA, Okla.
Sign-up for ONE Gas Third-quarter 2014 Conference Call and Webcast Scheduled investment picks
http://media.marketwire.com/attachments/201311/200689_Horizon_Logo_877.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1143338&ProfileId=051205&sourceType=1 BAAR, SWITZERLAND --
Sign-up for One Horizon and Singapore Telecommunications Limited ("SingTel") Sign Deal to Deliver Optimized VoIP to Smartphones for Mobile Satellite Users investment picks
http://media.marketwire.com/attachments/201311/200689_Horizon_Logo_877.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1137449&ProfileId=051205&sourceType=1 BAAR, SWITZERLAND --
Sign-up for One Horizon Group Announces Second Quarter 2014 Results investment picks
http://media.marketwire.com/attachments/201311/200689_Horizon_Logo_877.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1133558&ProfileId=051205&sourceType=1 BAAR, SWITZERLAND --
Sign-up for One Horizon Group Closes $1 Million Private Placement investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Oncolytics Biotech® Inc. Announces Second Quarter 2014 Results to One Horizon Group Closes $1 Million Private Placement
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices